CARDINALI, BARBARA
 Distribuzione geografica
Continente #
EU - Europa 187
AS - Asia 103
NA - Nord America 71
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 7
AF - Africa 1
Totale 380
Nazione #
IT - Italia 169
US - Stati Uniti d'America 69
CN - Cina 32
SG - Singapore 28
BD - Bangladesh 26
VN - Vietnam 10
DE - Germania 5
BR - Brasile 3
GB - Regno Unito 3
AT - Austria 2
FR - Francia 2
HK - Hong Kong 2
IN - India 2
NL - Olanda 2
AR - Argentina 1
BE - Belgio 1
CA - Canada 1
CH - Svizzera 1
CO - Colombia 1
FI - Finlandia 1
JM - Giamaica 1
JP - Giappone 1
PK - Pakistan 1
PY - Paraguay 1
SI - Slovenia 1
SN - Senegal 1
TR - Turchia 1
UY - Uruguay 1
Totale 369
Città #
Genoa 118
Vado Ligure 19
Singapore 18
San Jose 9
New York 6
Santa Clara 5
Shenzhen 5
Beijing 4
Ho Chi Minh City 4
Ashburn 3
Milan 3
Muggia 3
Stuttgart 3
Afragola 2
Boardman 2
Buffalo 2
Council Bluffs 2
El Paso 2
Frankfurt am Main 2
Hanoi 2
Haverhill 2
Hong Kong 2
Lauterbourg 2
London 2
Los Angeles 2
Orem 2
Piscataway 2
Queens 2
Vienna 2
Alameda 1
Asunción 1
Augusta 1
Bologna 1
Brussels 1
Bắc Giang 1
Calgary 1
Chennai 1
Chiavari 1
Chicago 1
City of London 1
Ciudad de la Costa 1
Columbus 1
Da Nang 1
Dakar 1
Dallas 1
Figino 1
Goiânia 1
Haiphong 1
Hephzibah 1
Houston 1
Istanbul 1
João Pessoa 1
Kingston 1
Knoxville 1
Lappeenranta 1
Ljubljana 1
Memphis 1
Minneapolis 1
Mola di Bari 1
Montgomery 1
Mumbai 1
Murfreesboro 1
Neiva 1
North Bergen 1
Ocala 1
Padua 1
Pasadena 1
Rowland Heights 1
Roxbury 1
San Juan 1
Scranton 1
Seattle 1
Spoleto 1
São Paulo 1
Taranto 1
Tokyo 1
Turin 1
Venice 1
Verona 1
Waterbury 1
Windermere 1
Zurich 1
Totale 285
Nome #
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology 113
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network 111
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study 92
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies 57
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial 7
Totale 380
Categoria #
all - tutte 1.075
article - articoli 1.075
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202415 0 0 0 0 0 0 0 3 3 0 5 4
2024/202571 2 2 2 3 7 6 5 16 2 4 12 10
2025/2026271 17 7 21 19 19 4 23 15 29 35 46 36
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 380